Ignite Creation Date:
2025-12-24 @ 3:02 PM
Ignite Modification Date:
2026-02-13 @ 8:44 AM
Study NCT ID:
NCT02174159
Status:
COMPLETED
Last Update Posted:
2023-04-10
First Post:
2014-06-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluation of Safety, Tolerability, Pharmacokinetics, and Antiretroviral Activity of Ulonivirine (MK-8507) in Human Immunodeficiency Virus (HIV-1)-Infected Participants (MK-8507-003)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-09-15
Start Date Type:
ACTUAL
Primary Completion Date:
2015-07-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-07-23
Completion Date Type:
ACTUAL
First Submit Date:
2014-06-24
First Submit QC Date:
None
Study First Post Date:
2014-06-25
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-04-06
Last Update Post Date:
2023-04-10
Last Update Post Date Type:
ACTUAL